Navigation Links
ShangPharma to Attend Two Upcoming Investor Conferences
Date:11/28/2011

SHANGHAI, Nov. 28, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it is scheduled to present at the following investor conferences in December 2011:

Ms. Lan Xie, Vice President of Finance and Investor Relations of ShangPharma, will present at the following conferences:

  • Deutsche Bank 5th Annual MedTools Investor Summit, December 5-6, 2011, Boston
  • Oppenheimer 22nd Annual Healthcare Conference, December 13-14, 2011, New York City

  • Presentation materials will be available under the Webcasts & Presentations section of the Company's investor relations website at http://ir.shangpharma.com.

    ABOUT SHANGPHARMA CORPORATIONShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.For further information, please contact:  ShangPharma Ms. Lan XieVP of Finance and Investor RelationsEmail: ir@shangpharma.comBrunswick GroupLilian WongEmail: shangpharma@brunswickgroup.com Phone: 86-10-5960-8600
    '/>"/>

    SOURCE ShangPharma Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ShangPharma Announces Third Quarter 2011 Results
    2. ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River
    3. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
    4. ShangPharma Corporation Announces Resignation of a Director
    5. ShangPharma Corporation to Hold 2011 Annual General Meeting on October 14, 2011
    6. ShangPharma Announces Up to $10 Million Share Repurchase Program
    7. ShangPharmas Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
    8. ShangPharma Corporation to Announce First Quarter 2011 Financial Results on May 19, 2011
    9. ShangPharma Corporation Files 2010 Annual Report on Form 20-F
    10. ShangPharma Announces Fourth Quarter and Fiscal Year 2010 Results
    11. ShangPharma to Present at the Citibank Global Health Care Conference from March 1 - 3, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/17/2017)... Management to Discuss Acquisition of ... KIT-302 Development On Track For An NDA ... Q1 2017   ... Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), an innovative biopharmaceutical company, ... rd at 8:30am Eastern Time to discuss the recent acquisition of a ...
    (Date:1/17/2017)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that ... 3 clinical trial comparing the efficacy and safety of ... of hepatic veno-occlusive disease (VOD) in adult and pediatric ... at high risk or at very high risk of ... across approximately 100 medical centers in the ...
    (Date:1/17/2017)... , Jan. 17, 2017  Edwards Lifesciences Corporation ... patient-focused innovations for structural heart disease and critical care ... quarter ended December 31, 2016 after the market closes ... conference call at 5:00 p.m. ET that day to ... conference call, dial (877) 407-8037 or (201) 689-8037.  For ...
    Breaking Medicine Technology:
    (Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... ... County, as well as Palm Desert, is opening a new office in San ... deep transcranial magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling with ...
    (Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... A prescription ... winners of the fourth Cradle to Cradle Product Design Challenge , the ... in a series of six circular design challenges scheduled to run through early 2018. ...
    (Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Livionex, Inc., ... results of a double blind clinical study for its dental gel that shows significant ... national brand of toothpaste containing triclosan. The study was conducted at the Beckman Laser ...
    (Date:1/17/2017)... ... ... Many people make New Year’s resolutions or renew their commitment to better health with the ... people who want to kick off 2017 with better smiles. Dr. Mondavi is offering several ... offers include: , , A new patient package for just $49, ...
    (Date:1/16/2017)... ... 2017 , ... California Southern University has named Dr. Steven Beazley University President. ... and as a core faculty member, teaching master’s and doctoral courses in the university’s ... Pepperdine University, where he earned his Doctor of Psychology degree in 1998. Dr. Beazley ...
    Breaking Medicine News(10 mins):